CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 63 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,163,720 | -33.9% | 370,500 | -24.1% | 0.01% | -33.3% |
| Q3 2022 | $3,272,000 | +426.9% | 488,300 | +230.8% | 0.01% | +350.0% |
| Q2 2022 | $621,000 | +181.0% | 147,600 | +125.0% | 0.00% | +100.0% |
| Q1 2022 | $221,000 | -26.6% | 65,600 | -31.2% | 0.00% | 0.0% |
| Q4 2021 | $301,000 | +85.8% | 95,400 | +92.7% | 0.00% | – |
| Q3 2021 | $162,000 | -16.9% | 49,500 | +6.9% | 0.00% | -100.0% |
| Q2 2021 | $195,000 | -51.1% | 46,300 | -42.1% | 0.00% | 0.0% |
| Q1 2021 | $399,000 | -66.1% | 80,000 | -14.2% | 0.00% | -66.7% |
| Q4 2020 | $1,178,000 | +18.5% | 93,200 | -7.9% | 0.00% | 0.0% |
| Q3 2020 | $994,000 | -19.1% | 101,200 | -18.0% | 0.00% | -25.0% |
| Q2 2020 | $1,228,000 | +13.1% | 123,392 | +0.4% | 0.00% | 0.0% |
| Q1 2020 | $1,086,000 | +2.5% | 122,900 | +7.1% | 0.00% | +100.0% |
| Q4 2019 | $1,059,000 | +65.5% | 114,800 | +5.5% | 0.00% | 0.0% |
| Q3 2019 | $640,000 | -48.9% | 108,800 | +4.2% | 0.00% | -33.3% |
| Q2 2019 | $1,253,000 | +74.3% | 104,400 | +75.2% | 0.00% | +50.0% |
| Q1 2019 | $719,000 | -16.2% | 59,600 | -12.9% | 0.00% | 0.0% |
| Q4 2018 | $858,000 | -20.9% | 68,400 | -6.4% | 0.00% | -33.3% |
| Q3 2018 | $1,085,000 | -6.5% | 73,100 | +6.1% | 0.00% | 0.0% |
| Q2 2018 | $1,160,000 | +15.4% | 68,900 | +56.9% | 0.00% | 0.0% |
| Q1 2018 | $1,005,000 | -32.8% | 43,900 | -24.1% | 0.00% | -25.0% |
| Q4 2017 | $1,496,000 | +1178.6% | 57,838 | +398.6% | 0.00% | – |
| Q3 2016 | $117,000 | -41.2% | 11,600 | -34.5% | 0.00% | -100.0% |
| Q2 2016 | $199,000 | -11.2% | 17,700 | +7.9% | 0.00% | 0.0% |
| Q1 2016 | $224,000 | -46.0% | 16,400 | -40.1% | 0.00% | -66.7% |
| Q1 2015 | $415,000 | – | 27,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |